Amgen
Data Breaches, Cyber Attacks and Security Report

https://amgen.com  ᛫  Biotech & Pharmaceuticals
Last updated December 7, 2019

About Amgen

Company Overview

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.

Valuation

$122,404,352,000

Employees

26,640

CEO

Robert A. Bradway

Location

Thousand Oaks, CA, United States.

Data Breaches and Security News

Amgen Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amgen is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Amgen

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Amgen's security performance with other companies